- Home
- AD vs VCYT Comparison
AD vs VCYT Comparison
Compare AD & VCYT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | AD | VCYT |
|---|---|---|
| Founded | 1983 | 2006 |
| Country | United States | United States |
| Employees | 60 | N/A |
| Industry | Telecommunications Equipment | Medical Specialities |
| Sector | Telecommunications | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.4B | 3.1B |
| IPO Year | N/A | 2013 |
Fundamental Metrics
Financial Performance| Metric | AD | VCYT |
|---|---|---|
| Price | $34.66 | $57.06 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 3 | 7 |
| Target Price | ★ $55.00 | $44.00 |
| AVG Volume (30 Days) | 302.4K | ★ 1.4M |
| Earning Date | 05-08-2026 | 05-05-2026 |
| Dividend Yield | ★ 69.43% | N/A |
| EPS Growth | N/A | ★ 164.52 |
| EPS | N/A | ★ 0.35 |
| Revenue | N/A | N/A |
| Revenue This Year | $33.57 | $13.76 |
| Revenue Next Year | N/A | $12.35 |
| P/E Ratio | $275.77 | ★ $162.77 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $34.09 | $22.61 |
| 52 Week High | $77.13 | $60.91 |
Technical Indicators
Market Signals| Indicator | AD | VCYT |
|---|---|---|
| Relative Strength Index (RSI) | 23.71 | 59.52 |
| Support Level | N/A | $40.27 |
| Resistance Level | $50.15 | $60.91 |
| Average True Range (ATR) | 1.34 | 2.87 |
| MACD | 0.10 | -0.44 |
| Stochastic Oscillator | 10.86 | 57.19 |
Price Performance
Historical ComparisonAbout AD Array Digital Infrastructure Inc.
Array Digital Infrastructure, formerly US Cellular, sold its regional wireless operations serving about 4.4 million customers to T-Mobile in August 2025. The firm has agreed to sell most of its remaining spectrum licenses; however, it will still retain rights to C-band spectrum in several locations after these deals are closed. Array also owns a 5.5% stake in Verizon Wireless' Los Angeles operations, as well as other smaller wireless partnership interests in Oklahoma and upstate New York. The firm still operates a portfolio of about 4,400 wireless towers. Parent TDS has proposed to acquire the portion of Array that it doesn't already own in an all-stock transaction.
About VCYT Veracyte Inc.
Veracyte Inc is a genomic diagnostics company. The group empowers clinicians with the insights necessary to guide and assure patients at pivotal moments in the race to diagnose and treat cancer. It offers tests for prostate cancer (Decipher Prostate), thyroid cancer (Afirma), breast cancer (Prosigna), and bladder cancer (Decipher Bladder).